SCHEMBL30455430

SCHEMBL30455430

CC(Nc1nc(NC2CC2)nc2ccccc12)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WHR1 P49842 1/20 0.62
▸ MAPT P10636 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ HTT P42858 1/20 0.58
▸ APP P05067 2/20 0.57
▸ BCHE P06276 2/20 0.57
▸ ACHE P22303 2/20 0.57
▸ CCNE2 O96020 4/20 0.55
▸ CCNE1 P24864 4/20 0.55
▸ CDK2 P24941 4/20 0.55
▸ CDK4 P11802 3/20 0.55
▸ CCND1 P24385 3/20 0.55
▸ KDM4E B2RXH2 4/20 0.55
▸ GAA P10253 3/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ NPY5R Q15761 2/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25867220 0.82 NPY5R (0.53) WHR1MAPTKMT2AMEN1HTT
SCHEMBL25867526 0.80 NPY5R (0.51) WHR1MAPTKMT2AMEN1HTT
SCHEMBL30456191 0.78 APP (0.60) MAPTKMT2AMEN1HTTAPP
SCHEMBL16280668 0.77 NPY5R (0.62) WHR1KMT2AMEN1APPBCHE
SCHEMBL22144633 0.77 WHR1 (1.00) WHR1APPBCHEACHENPY5R
SCHEMBL3948477 0.75 APP (0.59) WHR1APPBCHEACHENPY5R
SCHEMBL24649614 0.75 NPY5R (0.79) WHR1KMT2AMEN1APPBCHE
SCHEMBL25243367 0.75 MAPT (0.67) MAPTKMT2AMEN1HTTAPP
SCHEMBL5103688 0.73 KMT2A (1.00) MAPTKMT2AMEN1HTTCCNE2
SCHEMBL8890775 0.73 NPY5R (0.71) MAPTKMT2AMEN1HTTNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF UNIV AJOU IND ACADEMIC COOP FOUND (KR) 2025-02-13 — — US disclosed
WO-2023121429-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF 아주대학교산학협력단 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF ADORA2A, HCRTR1, ADORA1 WHR1 2275/4885MAPT 4331/4885KMT2A 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback